The genetic association between EGF A61G polymorphism (rs4444903) and risk of colorectal cancer
Authors:
Open Access
- 1 January 2019
- journal article
- review article
- Published by Wolters Kluwer Health in Medicine
- Vol. 98 (2) , e14007
Abstract
Background: Colorectal cancer was a complex disease with multiple causative factors including genetic and environmental factors, as well as the interaction of the 2 factors. Relationship between epidermal growth factor (EGF) A61G polymorphism and colorectal cancer risk has been widely investigated previously, whereas results derived from these studies were inconclusive and controversial. The aim of this study was to investigate the association between the EGF A61G polymorphism and colorectal cancer using a meta-analysis of existing literature. Methods: Literature search was conducted from PubMed, EMBASE, China National Knowledge Infrastructure, Wanfang, and Cochrane library databases before July 2017. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were used to evaluate the strength of the association between EGF A61G and colorectal cancer. Results: A total of 9 studies that involved 1448 cases and 1928 healthy controls and found allelic (OR = 1.18, P = .04) and recessive models (OR = 1.36, P = .03) of EGF A61G were significantly associated with the risk of colorectal cancer. Stratification analyses by ethnicity indicated that the EGF 61G significantly increased the risk of colorectal cancer in the Caucasian subgroup (OR = 1.24, P = .02), but not in Asian subgroup (OR = 1.12, P = .08). And the frequency of GG genotype of EGF A61G significantly increased in cases than that in healthy controls in both Caucasian (OR = 1.40, P = .04) and Asian subgroups (OR = 1.27, P = .01). Furthermore, the sample sources and genotyping methods seem to have no influence on the correction of EGF A61G and colorectal cancer susceptibility (P > .05). Conclusion: The results indicate that EGF A61G might increase the risk of colorectal cancers.Keywords
This publication has 31 references indexed in Scilit:
- Meta-Analysis of Epidermal Growth Factor Polymorphisms and Cancer Risk: Involving 9,779 Cases and 15,932 ControlsDNA and Cell Biology, 2012
- Cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2012
- Association betweenEGF+61A/G polymorphism and gastric cancer in CaucasiansWorld Journal of Gastroenterology, 2011
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Colorectal Cancer Epidemiology: Incidence, Mortality, Survival, and Risk FactorsClinics in Colon and Rectal Surgery, 2009
- EGF61A>G polymorphism as predictive marker of clinical outcome to first-line capecitabine and oxaliplatin in metastatic colorectal cancerAnnals of Oncology, 2009
- The EGF 61A/G polymorphism – a predictive marker for recurrence of liver metastases from colorectal cancerWiener klinische Wochenschrift, 2009
- The role of the EGFR signaling in tumor microenvironmentJournal of Cellular Physiology, 2007
- Variant genotypes and haplotypes of the epidermal growth factor gene promoter are associated with a decreased risk of gastric cancer in a high‐risk Chinese populationCancer Science, 2007
- Epidermal growth factor (EGF) A61G polymorphism and EGF gene expression in normal colon tissue from patients with colorectal cancerActa Oncologica, 2007